Alzheimer’s Disease – ACW0009

Join a clinical trial for Alzheimer’s Disease

This trial is aiming to see if a new potential treatment can improve memory and thinking. If there is someone in your life who is going through this, then share this with them.

Xanamem® is being developed as a potential treatment for symptomatic, early stages of Alzheimer’s Disease (AD) and Major Depressive Disorder (MDD).

Inclusion Criteria:

  • If receiving symptomatic AD medications, the dosing regimen must have been stable for 3 months prior to Screening.
  • If you are over 50 and experiencing memory and thinking issues, then this clinical trial may be right for you or a loved one.
  • Other criteria may apply

Complete the form and a member from the research team will contact you to determine your eligibility.

View Study on ClinicalTrials.gov

Trial Interest Form

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
Consent(Required)

Locations

The Neurology Center of Southern California

6010 Hidden Valley Road
Suites 200 & 205
Carlsbad, California